Fondaparinux overdosage: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(Created page with "__NOTOC__ {{Fondaparinux}} {{CMG}}; {{AE}} {{AZ}} ==Overdosage== *There is no known antidote for ARIXTRA. Overdose of ARIXTRA may lead to hemorrhagic complications. *'''Di...")
 
m (Protected "Fondaparinux overdosage": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)))
 
(4 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Fondaparinux#Overdosage]]
{{Fondaparinux}}
{{CMG}}; {{AE}} {{AZ}}


==Overdosage==
[[Category: Cardiovascular Drugs]]
 
[[Category: Drug]]
*There is no known antidote for ARIXTRA. Overdose of ARIXTRA may lead to hemorrhagic complications.
[[Category: Anticoagulants]]
 
*'''Discontinue treatment and initiate appropriate therapy if bleeding complications associated with overdosage occur'''.
 
*Data obtained in patients undergoing chronic intermittent hemodialysis suggest that clearance of ARIXTRA can increase by 20% during [[hemodialysis]].
 
==References==
{{Reflist}}
 
{{FDA}}
 
[[Category:Drugs]]

Latest revision as of 21:14, 18 August 2015

Redirect to:

Retrieved from "https://www.wikidoc.org/index.php?title=Fondaparinux_overdosage&oldid=1135416"